Biophysics and Medical Technology, Dept. of Physics, NTNU, Norwegian University of Science and Technology, NO-7491 Trondheim, Norway.
Lab Chip. 2021 Jun 1;21(11):2232-2243. doi: 10.1039/d1lc00111f.
Micron-sized alginate hydrogel beads are extensively employed as an encapsulation medium for biochemical and biomedical applications. Here we report on the microfluidic assisted fabrication of calcium alginate (Ca-alginate) beads by on-chip picoinjection of aqueous calcium chloride (CaCl2) in emulsified aqueous sodium alginate (Na-alginate) droplets or by picoinjection of Na-alginate solution in emulsified aqueous CaCl2 droplets. There is no added chelator to reduce the Ca activity in either of the two strategies. The two fabrication strategies are implemented using a flow-focusing and picoinjection modules in a single PDMS chip. Aqueous alginate solution was emulsified and infused with CaCl2 solution as the squeezed droplet pass the picoinjection channel; consequently, monodisperse, spherical, and structurally homogeneous Ca-alginate beads were obtained. Monodisperse alginate microgel populations with a mean diameter in the range of 8 to 28 μm and standard deviation less than 1 μm were successfully generated using microfluidic channels with various dimensions and controlling the flow parameters. Monodisperse but also non-spherical particles with diameters 6 to 15 μm were also fabricated when picoinjecting Na-alginate solution in emulsified aqueous CaCl2 droplets. The Ca-alginate microbeads fabricated with tailormade size in the range from sub-cellular and upwards were in both strategies realized without any use of chelators or change in pH conditions, which is considered a significant advantage for further exploitation as encapsulation process for improved enzymatic activity and cell viability.
微米级大小的海藻酸水凝胶珠被广泛用作生化和生物医学应用的封装介质。在这里,我们报告了在微流控芯片上通过在乳化的海藻酸钠(Na-alginate)液滴中皮升级微量注射氯化钙(CaCl2)或通过在乳化的氯化钙(CaCl2)液滴中皮升级微量注射海藻酸钠(Na-alginate)溶液,来制备海藻酸钙(Ca-alginate)珠。这两种策略都没有添加螯合剂来降低 Ca 的活性。这两种制造策略是在单个 PDMS 芯片中使用流聚焦和皮升级注模块来实现的。海藻酸钠溶液被乳化,并与 CaCl2 溶液一起注入,当挤出的液滴通过皮升级注通道时,会得到单分散的、球形的、结构均匀的 Ca-alginate 珠。使用具有不同尺寸的微通道并控制流动参数,成功地生成了具有 8 至 28 μm 范围内的平均直径和小于 1 μm 的标准偏差的单分散海藻酸钠微凝胶群体。当在乳化的氯化钙(CaCl2)液滴中皮升级微量注射海藻酸钠(Na-alginate)溶液时,也可以制备出单分散但非球形的粒径为 6 至 15 μm 的颗粒。通过这两种策略,无需使用螯合剂或改变 pH 值条件,即可制备出尺寸在亚细胞和以上范围内的定制化 Ca-alginate 微珠,这被认为是进一步开发作为封装过程的一个显著优势,以提高酶活性和细胞活力。